November 24, 2009
Gilead Sciences to Present at the NASDAQ OMX 23rd Investor Program
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov. 24, 2009--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company
will be webcasting its corporate presentation at the NASDAQ OMX 23rd
Investor Program in London.
Kevin Young, Gilead’s Executive Vice President of Commercial Operations,
will provide an overview of the company at the NASDAQ OMX Investor
Program on Tuesday, December 1 at 10:15 a.m. Greenwich Mean Time (5:15
a.m. EST).
To access the live webcast or a replay via the internet log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be necessary to listen to the webcast. The replay will
be available for 14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Australia.
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
(1-800-445-3235).
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor
Relations
